DURECT Corporation Reports Second Quarter 2022 Financial Results and Update of Programs
Aug 04, 2022, 16:05 ET – Webcast of Earnings Call Today, August 4th at 4:30 p.m. ET – Enrollment accelerating in the AHFIRM trial CUPERTINO, Calif., Aug. 4, 2022 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2022 and provided a corporate update. “We continue to […]
DURECT Corporation Reports Second Quarter 2022 Financial Results and Update of Programs Read More »